New asthma drug shows promise in taming tough coughs

NCT ID NCT05922891

Completed Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested the drug tezepelumab in 92 adults with severe asthma to see if it improves asthma control and reduces chronic cough. Participants took the drug as prescribed by their doctor, and researchers tracked their symptoms and quality of life for a year. The goal was to see how well the drug works in everyday medical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

Research Site

Aomori, Japan
Research Site

Bunkyō City, Japan
Research Site

Fujisawa, Japan
Research Site

Fukuoka, Japan
Research Site

Fukushima, Japan
Research Site

Hamamatsu, Japan
Research Site

Hiroshima, Japan
Research Site

Iizuka, Japan
Research Site

Izumo, Japan
Research Site

Kawasaki, Japan
Research Site

Kitakyushu, Japan
Research Site

Kiyose, Japan
Research Site

Kurashiki, Japan
Research Site

Matsusaka, Japan
Research Site

Minami, Japan
Research Site

Minato, Japan
Research Site

Nagoya, Japan
Research Site

Naka, Japan
Research Site

Niigata, Japan
Research Site

Nishinomiya, Japan
Research Site

Osaka, Japan
Research Site

Sapporo, Japan
Research Site

Shinagawa City, Japan
Research Site

Shinjuku, Japan
Research Site

Shizuoka, Japan
Research Site

tabashi City, Japan
Research Site

Tennōjichō-kita, Japan
Research Site

Ube, Japan
Research Site

Yonago, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.